MicroRNA as biomarker in ovarian cancer management: Advantages and challenges
Ovarian cancer is the most prevalent gynecological malignancy affecting women throughout
the globe. Ovarian cancer has several subtypes, including epithelial ovarian cancer (EOC) …
the globe. Ovarian cancer has several subtypes, including epithelial ovarian cancer (EOC) …
[HTML][HTML] MicroRNA: a new and promising potential biomarker for diagnosis and prognosis of ovarian cancer
MK Pal, SP Jaiswar, VN Dwivedi… - Cancer biology & …, 2015 - ncbi.nlm.nih.gov
Epithelial ovarian cancer (EOC) is the leading cause of death among all gynecological
malignancies. Despite the technological and medical advances over the past four decades …
malignancies. Despite the technological and medical advances over the past four decades …
MicroRNAs as biomarkers for early diagnosis, prognosis, and therapeutic targeting of ovarian cancer
Y Mirahmadi, R Nabavi, F Taheri… - Journal of …, 2021 - Wiley Online Library
Ovarian cancer is the major cause of gynecologic cancer‐related mortality. Regardless of
outstanding advances, which have been made for improving the prognosis, diagnosis, and …
outstanding advances, which have been made for improving the prognosis, diagnosis, and …
Current status and implications of microRNAs in ovarian cancer diagnosis and therapy
MS Zaman, DM Maher, S Khan, M Jaggi… - Journal of ovarian …, 2012 - Springer
Ovarian cancer is the fifth most common cancer among women and causes more deaths
than any other type of female reproductive cancer. Currently, treatment of ovarian cancer is …
than any other type of female reproductive cancer. Currently, treatment of ovarian cancer is …
Current strategies for early epithelial ovarian cancer detection using miRNA as a potential tool
M Bhadra, M Sachan, S Nara - Frontiers in Molecular Biosciences, 2024 - frontiersin.org
Ovarian cancer is one of the most aggressive and significant malignant tumor forms in the
female reproductive system. It is the leading cause of death among gynecological cancers …
female reproductive system. It is the leading cause of death among gynecological cancers …
The potential of MicroRNAs as clinical biomarkers to aid ovarian cancer diagnosis and treatment
Ovarian cancer is a commonly diagnosed malignancy in women. When diagnosed at an
early stage, survival outcomes are favourable for the vast majority, with up to 90% of ovarian …
early stage, survival outcomes are favourable for the vast majority, with up to 90% of ovarian …
Updates and current challenges in microRNA research for personalized medicine in ovarian cancer
V Mandilaras, M Vernon… - Expert Opinion on …, 2017 - Taylor & Francis
Introduction: Ovarian cancer (OC) is the second most common and the most lethal of the
gynecological malignancies. Currently, there exists no effective screening tool for OC …
gynecological malignancies. Currently, there exists no effective screening tool for OC …
MicroRNA in ovarian cancer: biology, pathogenesis, and therapeutic opportunities
SN Chen, R Chang, LT Lin, CU Chern, HW Tsai… - International journal of …, 2019 - mdpi.com
Ovarian cancer comprises one of the three major malignant tumor types in the female
reproductive system. The mortality rate of this cancer is the highest among all gynecological …
reproductive system. The mortality rate of this cancer is the highest among all gynecological …
The role of miRNA in ovarian cancer: an overview
L Zhao, X Liang, L Wang, X Zhang - Reproductive sciences, 2022 - Springer
Ovarian cancer (OC) is a highly malignant disease that seriously threatens women's health
and poses challenges for clinicians. MicroRNAs (miRNAs) have recently been intensively …
and poses challenges for clinicians. MicroRNAs (miRNAs) have recently been intensively …
miRNAs and ovarian cancer: An overview
B Deb, A Uddin, S Chakraborty - Journal of cellular physiology, 2018 - Wiley Online Library
Ovarian cancer (OC) is the sixth most common cancer in women globally. However, even
with the advances in detection and therapeutics it still represents the most dangerous …
with the advances in detection and therapeutics it still represents the most dangerous …
相关搜索
- advantages and challenges cancer management
- ovarian cancer diagnosis
- micrornas in prognosis ovarian cancer
- therapeutic targeting ovarian cancer
- personalized medicine in ovarian cancer
- therapy of ovarian cancer
- clinical biomarkers cancer diagnosis
- therapeutic targeting early diagnosis
- therapeutic opportunities ovarian cancer
- implications of micrornas cancer diagnosis